drugset
drugset / Trial / NCT07385235

Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'

NCT07385235 ↗

Phase 1 Recruiting 46 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.

Timeline

Start
2026-01-27
Primary completion
2026-03-07
Completion
2026-03-16

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-1151 Unknown 200 mg Oral
Subject AD-115A Unknown 200 mg Oral

Indications

gastric ulcer